SARC041: Study of Abemaciclib Versus Placebo in Patients With Advanced Dedifferentiated Liposarcoma
SARC041: Study of Abemaciclib Versus Placebo in Patients With Advanced Dedifferentiated Liposarcoma
Active, not recruiting · NCT04967521 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SARC041: Study of Abemaciclib Versus Placebo in Patients With Advanced Dedifferentiated Liposarcoma | Advanced Dedifferentiated Liposarcoma | Active, not recruiting | Phase 3 | 2026-10-05 | NCT04967521 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
| Sarcoma Alliance for Research through Collaboration | 7 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke University | Durham | United States | 160 |
| Massachusetts General Hospital Cancer Center | Boston | United States | 178 |
| Mayo Clinic Florida | Jacksonville | United States | 105 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Northwestern University | Chicago | United States | 727 |
| Oregon Health & Science University | Portland | United States | 261 |
| University of Colorado Cancer Center, Anschutz Medical Campus | Aurora | United States | 1 |
| University of Washington | Seattle | United States | 36 |
| Washington University School of Medicine | St Louis | United States | 1 |